课题基金 / 基金详情

CLINICAL TRIAL: A PHASE II TRIAL OF POLY-ICLC IN PATIENTS WITH RECURRENT ANAPLAS

CLINICAL TRIAL: A PHASE II TRIAL OF POLY-ICLC IN PATIENTS WITH RECURRENT ANAPLAS
临床试验:POLY-ICLC 在复发性 ANAPLAS 患者中的 II 期试验
批准号:
7717972
负责人:
TIMOTHY CLOUGHESY
金额:
$0.18万
依托单位国家:
美国
项目类别:
财政年份:
2007
资助国家:
美国
项目状态:
已结题
起止时间:
2007-12-01 至 2008-11-30

项目摘要

项目成果

TIMOTHY CLOUGHESY的其他基金

相关文献

中文摘要
翻译
这个子项目是许多研究子项目中的一个 由NIH/NCRR资助的中心赠款提供的资源。子项目和 研究者(PI)可能从另一个NIH来源获得了主要资金, 因此可以在其他CRISP条目中表示。所列机构为 研究中心,而研究中心不一定是研究者所在的机构。 主要目标:通过6个月无进展生存期确定Poly-ICLC在复发性间变性胶质瘤患者中的疗效。
英文摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. Primary objective: To determine the efficacy of Poly-ICLC in patients with recurrent anaplastic glioma as determined by 6 month progression-free survival.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Role of decorin and diffusion MRI in anti-VEGF efficacy for recurrent glioblastoma
Role of decorin and diffusion MRI in anti-VEGF efficacy for recurrent glioblastoma
Career Enhancement Program
Career Enhancement Program